Literature DB >> 9237937

Long-term oral supplementation with iron is not harmful for young children in a poor community of Bangladesh.

A K Mitra1, S M Akramuzzaman, G J Fuchs, M M Rahman, D Mahalanabis.   

Abstract

The effect of long-term oral iron supplementation on morbidity due to diarrhea, dysentery and respiratory infections in 349 children, aged 2-48 mo, living in a poor community of Bangladesh, was evaluated in this double-blind study. The treatment group received 125 mg of ferrous gluconate (15 mg elemental iron) plus multivitamins and the controls received only multivitamins, daily for 15 mo. House-to-house visits were made on alternate days by trained community health workers for recording symptoms and duration of illnesses and for monitoring medicine intake. Seventy-six percent of the children continued the syrup for over 1 y. No untoward effects were noticed in either treatment group. The attack rates for diarrhea, dysentery and acute respiratory tract infections (ARI) were 3, 3 and 5 episodes per child per year, respectively. Each episode of diarrhea lasted a mean of 3 d, and those of dysentery and ARI, 5 d. The two treatment groups did not differ in the number of episodes, mean duration of each episode, or total days of illnesses due to diarrhea, dysentery and ARI. However, a 49% greater number of episodes of dysentery was observed with iron supplementation in a subset of the study children who were less than 12 mo old (P = 0.03). The results of this study suggest that long-term oral iron supplementation is not harmful for older children in a poor community. Further studies are needed to demonstrate the safety and efficacy of iron administration in young infants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237937     DOI: 10.1093/jn/127.8.1451

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  13 in total

1.  Mass iron treatment is cheaper than routine deworming.

Authors:  Shailendra Kapoor
Journal:  BMJ       Date:  2007-06-09

Review 2.  Oral iron supplements for children in malaria-endemic areas.

Authors:  Ami Neuberger; Joseph Okebe; Dafna Yahav; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2016-02-27

Review 3.  Iron deficiency: beyond anemia.

Authors:  Dinesh Yadav; Jagdish Chandra
Journal:  Indian J Pediatr       Date:  2010-09-03       Impact factor: 1.967

Review 4.  Effect of iron supplementation on incidence of infectious illness in children: systematic review.

Authors:  Tarun Gera; H P S Sachdev
Journal:  BMJ       Date:  2002-11-16

5.  Burden of illness in the first 3 years of life in an Indian slum.

Authors:  Beryl P Gladstone; Ashima R Das; Andrea M Rehman; Shabbar Jaffar; Mary K Estes; Jayaprakash Muliyil; Gagandeep Kang; Anuradha Bose
Journal:  J Trop Pediatr       Date:  2009-12-22       Impact factor: 1.165

Review 6.  Iron supplementation in early childhood: health benefits and risks.

Authors:  Lora L Iannotti; James M Tielsch; Maureen M Black; Robert E Black
Journal:  Am J Clin Nutr       Date:  2006-12       Impact factor: 7.045

7.  Impact of long-term oral iron supplementation in breast-fed infants.

Authors:  Nabil Abdelrazik; Mohammad Al-Haggar; Hala Al-Marsafawy; Hesham Abdel-Hadi; Rizk Al-Baz; Abdel-Hamid Mostafa
Journal:  Indian J Pediatr       Date:  2007-08       Impact factor: 1.967

8.  The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D).

Authors:  C L Raison; A H Miller
Journal:  Mol Psychiatry       Date:  2012-01-31       Impact factor: 15.992

Review 9.  Systematic review of diarrhea duration and severity in children and adults in low- and middle-income countries.

Authors:  Laura M Lamberti; Christa L Fischer Walker; Robert E Black
Journal:  BMC Public Health       Date:  2012-04-06       Impact factor: 3.295

10.  Infant morbidity in an Indian slum birth cohort.

Authors:  B P Gladstone; J P Muliyil; S Jaffar; J G Wheeler; A Le Fevre; M Iturriza-Gomara; J J Gray; A Bose; M K Estes; D W Brown; G Kang
Journal:  Arch Dis Child       Date:  2007-10-04       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.